What does Anglo French Drugs and Industries Limited manufacture?

Anglo French Drugs and Industries Limited manufactures pharmaceutical formulations including tablets, capsules, syrups, and ointments across multiple therapeutic categories such as analgesics, anti-infectives, vitamins, and general medicine.

When was Anglo French Drugs incorporated?

The company was incorporated in 1963 under the Companies Act with CIN L24231MH1963PLC012544, making it one of India's oldest private pharmaceutical companies.

Is Anglo French Drugs listed on a stock exchange?

Anglo French Drugs and Industries Limited is not listed on BSE or NSE. However, it has an assigned ISIN (INE437D01012) and its shares are available on unlisted/pre-IPO markets.

What is the ISIN for Anglo French Drugs?

The ISIN for Anglo French Drugs and Industries Limited is INE437D01012.

What is the current unlisted share price of Anglo French Drugs?

The unlisted share price is approximately ₹1,078 per share as tracked by unlisted share market intermediaries.

Who are the promoters of Anglo French Drugs?

The company has historically been promoted by the Mehta family. Detailed current shareholding can be verified through MCA filings.

Does Anglo French Drugs export pharmaceutical products?

Yes, Anglo French Drugs has historically had an export presence, supplying pharmaceutical formulations to select international markets in addition to its domestic operations.

How do I buy Anglo French Drugs & Industries unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Anglo French Drugs & Industries?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Anglo French Drugs & Industries shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Anglo French Drugs & Industries Unlisted Share Price | Buy Anglo French Drugs & Industries Pre-IPO Shares — wisefolio

Investment Thesis

Anglo French Drugs and Industries Limited is a legacy Mumbai-based pharmaceutical company with over six decades of operating history. While it lacks the scale and public visibility of its listed peers, it benefits from an established brand and product portfolio. The unlisted share market values it at approximately ₹1,078 per share, indicating modest investor interest. Investors should conduct thorough due diligence through MCA filings given limited public disclosures.

Pros

One of India's oldest pharmaceutical companies with over 60 years of operational history since 1963
Diversified product portfolio spanning multiple therapeutic segments including analgesics, antibiotics, and vitamins
Long-standing brand reputation built over decades across Indian and export markets
Listed on unlisted share markets with ISIN INE437D01012, indicating regulatory compliance and proper corporate structure
Operates in the resilient pharmaceutical sector which showed consistent demand even during economic downturns
Potential to benefit from India's growing pharmaceutical export push and domestic healthcare expansion

Cons

Company is unlisted on major exchanges, limiting liquidity for investors
Limited public financial disclosure compared to listed pharma peers
Relatively small scale compared to listed Indian pharma giants like Sun Pharma, Cipla, or Dr. Reddy's
The Indian generic pharma sector faces significant pricing pressure from government NPPA regulations
Aging company structure may face challenges modernizing manufacturing to meet updated GMP norms

Business Segments

Pharmaceutical Formulations

Manufacturing and marketing of finished dosage forms including tablets, capsules, syrups, and topical formulations across therapeutic categories

Active Pharmaceutical Ingredients (APIs)

Production or procurement of active pharmaceutical ingredients used in formulation manufacturing

Exports

Supply of pharmaceutical products to select international markets

Revenue Model

Anglo French Drugs generates revenue through the manufacture and sale of branded and generic pharmaceutical formulations to domestic distributors, hospitals, and pharmacies, as well as through export contracts. Revenue is transaction-based on bulk sales to stockists and institutional buyers.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds12

Growth Plans

India's domestic pharmaceutical market expected to grow to $130 billion by 2030

Increased government healthcare spending under Ayushman Bharat and similar schemes

Potential future IPO listing which could unlock significant value

Export market expansion leveraging India's reputation as a generic drug supplier

Industry Tailwinds

Recent Developments

Unlisted share market activity

Anglo French Drugs shares are actively traded on the Indian unlisted share market, reflecting investor interest in legacy pharmaceutical companies with established operations.

India pharmaceutical sector tailwinds

India's pharmaceutical sector continues to grow, driven by rising domestic healthcare expenditure and strong API and generic drug exports, which benefits established manufacturers like Anglo French Drugs.

Comparable Companies

CompanyTypeTickerMkt Cap

Abbott India LimitedListedABBOTINDIA~45,000 Cr

Pfizer India LimitedListedPFIZER~25,000 Cr

Alkem LaboratoriesListedALKEM~35,000 Cr

FDC LimitedListedFDC~5,000 Cr

Frequently Asked Questions

About Anglo French Drugs & Industries

Anglo French Drugs and Industries Limited is a Mumbai-based pharmaceutical company incorporated in 1963, one of India's older pharma manufacturers with over 60 years of operating history. The company is engaged in the manufacture and marketing of pharmaceutical formulations, active pharmaceutical ingredients (APIs), and related healthcare products. Anglo French Drugs has a diverse pharmaceutical product portfolio spanning multiple therapeutic segments including antibiotics, analgesics, anti-infectives, and other formulations. The company's manufacturing operations serve both domestic Indian markets and export markets, leveraging India's position as the world's pharmacy, supplying over 60% of global vaccine requirements and 20% of global generic medicines. The Indian pharmaceutical industry is a Rs 4.16 lakh crore market growing at approximately 11% annually, driven by rising healthcare spending, increasing chronic disease burden, government health insurance expansion, and growing pharmaceutical exports. Companies like Anglo French Drugs benefit from India's cost-competitive manufacturing base, skilled scientific workforce, and established regulatory compliance capabilities. The company's Mumbai headquarters provides access to India's largest pharma hub — Maharashtra houses some of India's most significant pharmaceutical manufacturing clusters. With 60+ years of operational history, Anglo French Drugs has built institutional knowledge in pharmaceutical manufacturing, regulatory compliance, and market relationships that represent significant barriers to entry for new competitors.

Key Milestones

1963 — Incorporated as Anglo French Drugs and Industries Limited in Mumbai under the Companies Act

Common questions about unlisted shares

How do I buy Anglo French Drugs & Industries unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Anglo French Drugs and Industries Limited

How settlement works

Get price alerts for Anglo French Drugs and Industries Limited

Discuss Anglo French Drugs & Industries

Similar companies

Other ways to invest